PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
11-Beta-Hydroxylase 721 Target Disease Inflammation 252,734 1 0.00 -1.00 0.00 0.49
11-Beta-Hydroxylase 721 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.00 0.50
11-Beta-Hydroxylase 721 Target Disease Asthma 109,610 1 0.00 -1.00 0.00 0.51
11-Beta-Hydroxylase 721 Target Disease Breast Cancer 173,695 4 0.00 -1.00 0.01 0.53
11-Beta-Hydroxylase 721 Target Disease Seizures 66,465 3 0.00 -1.00 0.00 0.54
11-Beta-Hydroxylase 721 Target Disease Infertility 35,448 8 0.00 -0.99 0.01 0.59
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Infection 766,637 2 0.00 -1.00 0.01 0.50
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Cholesterol 182,390 1 0.00 -1.00 0.00 0.52
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Anxiety 113,510 1 0.00 -1.00 0.00 0.53
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Depression 220,092 2 0.00 -1.00 0.01 0.53
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Leukemia 162,805 2 0.00 -1.00 0.01 0.53
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Obesity 138,233 2 0.00 -1.00 0.01 0.54
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Ovarian Cancer 33,996 1 0.00 -1.00 0.00 0.55
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Inflammation 252,734 3 0.00 -0.99 0.01 0.53
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Lung Carcinoma 13,423 1 0.00 -1.00 0.00 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Diabetic Nephropathy 12,496 1 0.00 -1.00 0.00 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Mesothelioma 11,198 1 0.00 -1.00 0.00 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Infertility 35,448 2 0.00 -1.00 0.01 0.57
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Lung Cancer 91,416 4 0.00 -0.99 0.02 0.56
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Shock 134,031 5 0.00 -0.99 0.02 0.56
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Glioblastoma 17,933 2 0.00 -1.00 0.01 0.59
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Testicular Cancer 4,459 1 0.00 -1.00 0.00 0.61
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Familial Adenomatous Polyposis 3,742 1 0.00 -1.00 0.00 0.61
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Carcinoma 433,099 11 0.00 -0.98 0.05 0.55
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Hyperglycemia 28,168 3 0.00 -0.99 0.01 0.59
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Viral Disease 2,087 1 0.00 -1.00 0.00 0.63
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Prostate Cancer 71,064 6 0.00 -0.99 0.03 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Breast Cancer 173,695 13 0.00 -0.97 0.06 0.58
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Disease Cancer 1,053,491 55 0.00 -0.87 0.24 0.57
4-1BB Ligand 135 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.01 0.53
4-1BB Ligand 135 Target Disease Arthritis 128,324 1 0.00 -1.00 0.01 0.53
4-1BB Ligand 135 Target Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
4-1BB Ligand 135 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -1.00 0.01 0.55
4-1BB Ligand 135 Target Disease Sepsis 64,798 1 0.00 -1.00 0.01 0.55
4-1BB Ligand 135 Target Disease Multiple Myeloma 24,594 1 0.00 -1.00 0.01 0.57
4-1BB Ligand 135 Target Disease Leukemias 14,152 1 0.00 -1.00 0.01 0.59
4-1BB Ligand 135 Target Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -1.00 0.01 0.59
4-1BB Ligand 135 Target Disease Organ Transplantation 11,384 1 0.00 -1.00 0.01 0.59
4-1BB Ligand 135 Target Disease Myelodysplastic Syndrome 7,378 1 0.00 -1.00 0.01 0.60
4-1BB Ligand 135 Target Disease Inflammation 252,734 7 0.00 -0.97 0.05 0.56
4-1BB Ligand 135 Target Disease Keratitis 10,599 2 0.00 -0.99 0.01 0.61
4-1BB Ligand 135 Target Disease Leukemia 162,805 9 0.00 -0.97 0.07 0.58
4-1BB Ligand 135 Target Disease Influenza 67,933 6 0.00 -0.98 0.04 0.59
4-1BB Ligand 135 Target Disease Lung Carcinoma 13,423 3 0.00 -0.99 0.02 0.62
4-1BB Receptor 20 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
4-1BB Receptor 20 Target Disease Infection 766,637 2 0.00 -0.95 0.10 0.55
4-1BB Receptor 20 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
4-1BB Receptor 20 Target Disease Tuberculosis 146,217 1 0.00 -0.97 0.05 0.56
4-1BB Receptor 20 Target Disease Shock 134,031 1 0.00 -0.97 0.05 0.57
4-1BB Receptor 20 Target Disease Influenza 67,933 1 0.00 -0.97 0.05 0.58
4-1BB Receptor 20 Target Disease Lung Carcinoma 13,423 1 0.00 -0.97 0.05 0.62
4-1BB Receptor 20 Target Disease Conjunctivitis 8,825 1 0.00 -0.97 0.05 0.63
4-Mercaptobenzoic Acid 70 Drug Disease Malaria 56,215 1 0.00 -0.99 0.01 0.56
4-Mercaptobenzoic Acid 70 Drug Disease Hepatitis 163,842 2 0.00 -0.99 0.03 0.56
4-Mercaptopyridine 96 Drug Disease Cancer 1,053,491 1 0.00 -0.99 0.01 0.50
4-Mercaptopyridine 96 Drug Disease Leukemia 162,805 2 0.00 -0.99 0.02 0.55
4-Mercaptopyridine 96 Drug Disease Glioblastoma 17,933 1 0.00 -0.99 0.01 0.59
464.1 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
464.1 19 Target Disease Cholesterol 182,390 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Asthma 109,610 1 0.00 -0.97 0.05 0.57
464.1 19 Target Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
5-Hydroxytryptamine 2a Receptor 67 Target Disease Inflammation 252,734 1 0.00 -0.99 0.01 0.53
5-Hydroxytryptamine 2a Receptor 67 Target Disease Pain 409,851 2 0.00 -0.98 0.03 0.54
5-Hydroxytryptamine 2a Receptor 67 Target Disease Seizures 66,465 1 0.00 -0.99 0.01 0.56
5-Hydroxytryptamine 2a Receptor 67 Target Disease Psoriasis 26,882 1 0.00 -0.99 0.01 0.58
5-Hydroxytryptamine 2a Receptor 67 Target Disease Autism 20,962 1 0.00 -0.99 0.01 0.59
5-Hydroxytryptamine 2a Receptor 67 Target Disease Mania 7,698 1 0.00 -0.99 0.01 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Disease Obesity 138,233 1 0.00 -0.97 0.06 0.57
5-Hydroxytryptamine 2b Receptor 18 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.06 0.59
5-Hydroxytryptamine 2b Receptor 18 Target Disease Migraine 24,200 1 0.00 -0.97 0.06 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.97 0.06 0.62
5-Hydroxytryptamine 2b Receptor 18 Target Disease Heart Disease 118,291 5 0.00 -0.85 0.28 0.61
5-Hydroxytryptamine 2b Receptor 18 Target Disease Central Nervous System Diseases 715 1 0.01 -0.97 0.06 0.70
744.1 22 Target Disease Carcinoma 433,099 1 0.00 -0.98 0.05 0.54
744.1 22 Target Disease Hepatitis 163,842 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Leukemia 162,805 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Stroke 146,992 1 0.00 -0.98 0.05 0.56
744.1 22 Target Disease Inflammation 252,734 2 0.00 -0.95 0.09 0.57
744.1 22 Target Disease Liver Disease 49,817 1 0.00 -0.98 0.05 0.59
744.1 22 Target Disease Heart Disease 118,291 2 0.00 -0.95 0.09 0.58
744.1 22 Target Disease Chronic Obstructive Pulmonary Disease 27,780 1 0.00 -0.98 0.05 0.60
744.1 22 Target Disease Dyslipidemia 15,225 1 0.00 -0.98 0.05 0.61
744.1 22 Target Disease Cardiac Arrest 20,700 2 0.00 -0.95 0.09 0.62
744.1 22 Target Disease Acute Promyelocytic Leukemia 4,780 1 0.00 -0.98 0.05 0.64
A1AT 329 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.00 0.52
A1AT 329 Target Disease Anemia 81,663 1 0.00 -1.00 0.00 0.53
A1AT 329 Target Disease Renal Failure 73,993 1 0.00 -1.00 0.00 0.53
A1AT 329 Target Disease Cholesterol 182,390 2 0.00 -1.00 0.01 0.53
A1AT 329 Target Disease Leukemia 162,805 2 0.00 -1.00 0.01 0.53
A1AT 329 Target Disease Proteinuria 28,803 1 0.00 -1.00 0.00 0.55
A1AT 329 Target Disease Pain 409,851 4 0.00 -0.99 0.01 0.52
A1AT 329 Target Disease Menopause 19,680 1 0.00 -1.00 0.00 0.56
A1AT 329 Target Disease Breast Cancer 173,695 3 0.00 -1.00 0.01 0.54
A1AT 329 Target Disease Nephrotic Syndrome 14,681 1 0.00 -1.00 0.00 0.57
A1AT 329 Target Disease Bacterial Infections 14,248 1 0.00 -1.00 0.00 0.57
A1AT 329 Target Disease Down Syndrome 10,290 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Respiratory Tract Infections 9,721 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Ankylosing Spondylitis 9,665 1 0.00 -1.00 0.00 0.58
A1AT 329 Target Disease Acute Coronary Syndromes 9,133 1 0.00 -1.00 0.00 0.58